Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00922272
What this trial is testing

Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms

Who this might be right for
Schizophrenia and Predominant Negative Symptoms
Shire 92
Not applicableStudy completedNCT00952757
What this trial is testing

Changes in Hyperprolactinemia Secondary to Antipsychotics After Switching to Quetiapine

Who this might be right for
APS-related HyperprolactinaemiaSchizophreniaBipolar Disorder
Investigaciones Médicas Montejo S.L. 35
Early research (Phase 1)Study completedNCT02184767
What this trial is testing

Study to Assess the Safety and Pharmacokinetics of ADASUVE® at Doses of 2.5, 5, or 10 mg in Children and Adolescents (10 Through 17 Years of Age) With Any Condition Warranting Chronic Use of an Antipsychotic Medication

Who this might be right for
BiPolar
Teva Branded Pharmaceutical Products R&D, Inc. 30
Post-approval studies (Phase 4)Study completedNCT01724359
What this trial is testing

Tolerability, Safety and Efficacy of Flexibly Dosed Paliperidone ER in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Janssen-Cilag, S.A. 95
Large-scale testing (Phase 3)Study completedNCT01811459
What this trial is testing

Trial Comparing Haloperidol, Quetiapine and Placebo in the Pharmacological Treatment of Delirium

Who this might be right for
Delirium
Centre hospitalier de l'Université de Montréal (CHUM) 107
Large-scale testing (Phase 3)Study completedNCT01192906
What this trial is testing

RO4917838 (Bitopertin) in Patients With Persistent, Predominant Negative Symptoms of Schizophrenia (WN25309)

Who this might be right for
Schizophrenia
Hoffmann-La Roche 624
Not applicableStudy completedNCT00894738
What this trial is testing

Measurement of Cardiometabolic Risk in Antipsychotic-Treated Children

Who this might be right for
Mental Disorders
Washington University School of Medicine 44
Testing effectiveness (Phase 2)Ended earlyNCT03351244
What this trial is testing

This Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months

Who this might be right for
Schizophrenia
Boehringer Ingelheim 264
Testing effectiveness (Phase 2)Study completedNCT00357006
What this trial is testing

A Definitive Estrogen Patch Study (ADEPT)

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder(Not in Manic Phase)
The Alfred 180
Not applicableUnknownNCT00201292
What this trial is testing

Pharmacogenetic Profiling of Antipsychotics-Induced X-Syndrome and Diabetes (PAXD)

Who this might be right for
Metabolic SyndromeDiabetes
National Health Research Institutes, Taiwan 1,350
Post-approval studies (Phase 4)UnknownNCT04446234
What this trial is testing

Atypical Antipsychotics Influence on the Safety of the Heart and Monitoring Indicators Model Building

Who this might be right for
Schizophrenia
Shanghai Mental Health Center 350
Not applicableEnded earlyNCT00833300
What this trial is testing

Haloperidol vs Olanzapine for the Management of ICU Delirium

Who this might be right for
DeliriumAgitation
Richard Hall 200
Not applicableStudy completedNCT01534936
What this trial is testing

Atypical Antipsychotics in the Treatment of Affective Symptoms of Schizophrenia in Hungary

Who this might be right for
SchizophreniaAffective Symptoms
AstraZeneca 2,153
Not applicableStudy completedNCT02958800
What this trial is testing

Deprescribing Antipsychotics in Long-Term Care

Who this might be right for
DementiaBehavior
McMaster University 6
Post-approval studies (Phase 4)Study completedNCT05663749
What this trial is testing

Topiramate vs Metformin on Cardio-Metabolic Profile in Schizophrenia on Atypical Antipsychotics

Who this might be right for
Metabolic SyndromeSchizophrenia
All India Institute of Medical Sciences, Bhubaneswar 60
Post-approval studies (Phase 4)Study completedNCT00761579
What this trial is testing

Paliperidone Extended Release(ER) Effectiveness Study to Evaluate the Objective Symptom Change and Symptomatic Remission

Who this might be right for
Schizophrenia
Janssen Korea, Ltd., Korea 190
Large-scale testing (Phase 3)Study completedNCT01291511
What this trial is testing

Relapse Prevention Study in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Vanda Pharmaceuticals 635
Post-approval studies (Phase 4)Study completedNCT04898270
What this trial is testing

Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia Patients

Who this might be right for
Schizophrenia; PsychosisMetabolic SyndromeFlupentixol+5 more
Taichung Veterans General Hospital 30
Post-approval studies (Phase 4)Study completedNCT00816907
What this trial is testing

The Use of Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (The METS Study)

Who this might be right for
Schizophrenia
National Institute of Mental Health (NIMH) 146
Post-approval studies (Phase 4)Study completedNCT00216671
What this trial is testing

Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute Episode

Who this might be right for
Schizophrenia
Janssen Pharmaceutica N.V., Belgium 220
Next Page